BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 23637631)

  • 1. Breakpoint analysis of transcriptional and genomic profiles uncovers novel gene fusions spanning multiple human cancer types.
    Giacomini CP; Sun S; Varma S; Shain AH; Giacomini MM; Balagtas J; Sweeney RT; Lai E; Del Vecchio CA; Forster AD; Clarke N; Montgomery KD; Zhu S; Wong AJ; van de Rijn M; West RB; Pollack JR
    PLoS Genet; 2013 Apr; 9(4):e1003464. PubMed ID: 23637631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of gene mutations and gene-gene fusions in circulating cell-free DNA of glioblastoma patients: an avenue for clinically relevant diagnostic analysis.
    Palande V; Siegal T; Detroja R; Gorohovski A; Glass R; Flueh C; Kanner AA; Laviv Y; Har-Nof S; Levy-Barda A; Viviana Karpuj M; Kurtz M; Perez S; Raviv Shay D; Frenkel-Morgenstern M
    Mol Oncol; 2022 May; 16(10):2098-2114. PubMed ID: 34875133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fusion of EML1 to ABL1 in T-cell acute lymphoblastic leukemia with cryptic t(9;14)(q34;q32).
    De Keersmaecker K; Graux C; Odero MD; Mentens N; Somers R; Maertens J; Wlodarska I; Vandenberghe P; Hagemeijer A; Marynen P; Cools J
    Blood; 2005 Jun; 105(12):4849-52. PubMed ID: 15713800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rare but Recurrent ROS1 Fusions Resulting From Chromosome 6q22 Microdeletions are Targetable Oncogenes in Glioma.
    Davare MA; Henderson JJ; Agarwal A; Wagner JP; Iyer SR; Shah N; Woltjer R; Somwar R; Gilheeney SW; DeCarvalo A; Mikkelson T; Van Meir EG; Ladanyi M; Druker BJ
    Clin Cancer Res; 2018 Dec; 24(24):6471-6482. PubMed ID: 30171048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of inflammatory myofibroblastic tumors with frequent ALK and ROS1 gene fusions and rare novel RET rearrangement.
    Antonescu CR; Suurmeijer AJ; Zhang L; Sung YS; Jungbluth AA; Travis WD; Al-Ahmadie H; Fletcher CD; Alaggio R
    Am J Surg Pathol; 2015 Jul; 39(7):957-67. PubMed ID: 25723109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ALK, ROS1 and RET fusions in 1139 lung adenocarcinomas: a comprehensive study of common and fusion pattern-specific clinicopathologic, histologic and cytologic features.
    Pan Y; Zhang Y; Li Y; Hu H; Wang L; Li H; Wang R; Ye T; Luo X; Zhang Y; Li B; Cai D; Shen L; Sun Y; Chen H
    Lung Cancer; 2014 May; 84(2):121-6. PubMed ID: 24629636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and cytogenetic characterization of a novel translocation t(4;22) involving the breakpoint cluster region and platelet-derived growth factor receptor-alpha genes in a patient with atypical chronic myeloid leukemia.
    Safley AM; Sebastian S; Collins TS; Tirado CA; Stenzel TT; Gong JZ; Goodman BK
    Genes Chromosomes Cancer; 2004 May; 40(1):44-50. PubMed ID: 15034867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptome sequencing to detect gene fusions in cancer.
    Maher CA; Kumar-Sinha C; Cao X; Kalyana-Sundaram S; Han B; Jing X; Sam L; Barrette T; Palanisamy N; Chinnaiyan AM
    Nature; 2009 Mar; 458(7234):97-101. PubMed ID: 19136943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of
    Reguart N; Teixidó C; Giménez-Capitán A; Paré L; Galván P; Viteri S; Rodríguez S; Peg V; Aldeguer E; Viñolas N; Remon J; Karachaliou N; Conde E; Lopez-Rios F; Nadal E; Merkelbach-Bruse S; Büttner R; Rosell R; Molina-Vila MA; Prat A
    Clin Chem; 2017 Mar; 63(3):751-760. PubMed ID: 28073897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A BCR-JAK2 fusion gene as the result of a t(9;22)(p24;q11.2) translocation in a patient with a clinically typical chronic myeloid leukemia.
    Griesinger F; Hennig H; Hillmer F; Podleschny M; Steffens R; Pies A; Wörmann B; Haase D; Bohlander SK
    Genes Chromosomes Cancer; 2005 Nov; 44(3):329-33. PubMed ID: 16001431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of KIF5B-RET and GOPC-ROS1 fusions in lung adenocarcinomas through a comprehensive mRNA-based screen for tyrosine kinase fusions.
    Suehara Y; Arcila M; Wang L; Hasanovic A; Ang D; Ito T; Kimura Y; Drilon A; Guha U; Rusch V; Kris MG; Zakowski MF; Rizvi N; Khanin R; Ladanyi M
    Clin Cancer Res; 2012 Dec; 18(24):6599-608. PubMed ID: 23052255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ROS1 fusions in cancer: a review.
    Uguen A; De Braekeleer M
    Future Oncol; 2016 Aug; 12(16):1911-28. PubMed ID: 27256160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequencies of the breakpoint cluster region types of the BCR/ABL fusion gene in Mexican Mestizo patients with chronic myelogenous leukemia.
    Ruiz-Argüelles GJ; Garcés-Eisele J; Reyes-Núñez V; Ruiz-Delgado GJ
    Rev Invest Clin; 2004; 56(5):605-8. PubMed ID: 15776864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative TEL-JAK2 fusions associated with T-cell acute lymphoblastic leukemia and atypical chronic myelogenous leukemia dissected in zebrafish.
    Onnebo SM; Rasighaemi P; Kumar J; Liongue C; Ward AC
    Haematologica; 2012 Dec; 97(12):1895-903. PubMed ID: 22733019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal Growth Factor Receptor (EGFR) Mutations and Anaplastic Lymphoma Kinase/Oncogene or C-Ros Oncogene 1 (ALK/ROS1) Fusions Inflict Non-Small Cell Lung Cancer (NSCLC) Female Patients Older Than 60 Years of Age.
    Ke L; Xu M; Jiang X; Sun X
    Med Sci Monit; 2018 Dec; 24():9364-9369. PubMed ID: 30580372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intergenic Breakpoints Identified by DNA Sequencing Confound Targetable Kinase Fusion Detection in NSCLC.
    Li W; Liu Y; Li W; Chen L; Ying J
    J Thorac Oncol; 2020 Jul; 15(7):1223-1231. PubMed ID: 32151779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel targets in non-small cell lung cancer: ROS1 and RET fusions.
    Gainor JF; Shaw AT
    Oncologist; 2013; 18(7):865-75. PubMed ID: 23814043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single-tube multiplexed assay for detecting ALK, ROS1, and RET fusions in lung cancer.
    Lira ME; Choi YL; Lim SM; Deng S; Huang D; Ozeck M; Han J; Jeong JY; Shim HS; Cho BC; Kim J; Ahn MJ; Mao M
    J Mol Diagn; 2014 Mar; 16(2):229-43. PubMed ID: 24418728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analyzing Somatic Genome Rearrangements in Human Cancers by Using Whole-Exome Sequencing.
    Yang L; Lee MS; Lu H; Oh DY; Kim YJ; Park D; Park G; Ren X; Bristow CA; Haseley PS; Lee S; Pantazi A; Kucherlapati R; Park WY; Scott KL; Choi YL; Park PJ
    Am J Hum Genet; 2016 May; 98(5):843-856. PubMed ID: 27153396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinase gene fusions in defined subsets of melanoma.
    Turner J; Couts K; Sheren J; Saichaemchan S; Ariyawutyakorn W; Avolio I; Cabral E; Glogowska M; Amato C; Robinson S; Hintzsche J; Applegate A; Seelenfreund E; Gonzalez R; Wells K; Bagby S; Tentler J; Tan AC; Wisell J; Varella-Garcia M; Robinson W
    Pigment Cell Melanoma Res; 2017 Jan; 30(1):53-62. PubMed ID: 27864876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.